(Q47561672)

4 February 2018

title

Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. (English)

1 reference

4 February 2018

Mycobacterium tuberculosis

main subject

0 references

1 reference

3

1 reference

4 February 2018

James Harris

object named as

James Harris

series ordinal

1

0 references

Jayne C. Hope

object named as

Jayne C Hope

series ordinal

2

1 reference

ORCID Public Data File 2021

language of work or name

English

0 references

publication date

1 December 2008

1 reference

4 February 2018

Journal of Infectious Diseases

published in

1 reference

4 February 2018

volume

198

1 reference

4 February 2018

page(s)

1842-1850

1 reference

4 February 2018

issue

12

1 reference

4 February 2018

Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence

cites work

1 reference

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology

21 January 2018

1 reference

Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology

21 January 2018

1 reference

Tumor necrosis factor is critical to control tuberculosis infection

21 January 2018

1 reference

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

21 January 2018

1 reference

Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis

21 January 2018

1 reference

Anti-cytokine therapeutics and infections

21 January 2018

1 reference

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

21 January 2018

1 reference

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

21 January 2018

1 reference

A vitellogenic-like carboxypeptidase expressed by human macrophages is localized in endoplasmic reticulum and membrane ruffles

21 January 2018

1 reference

T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis.

21 January 2018

1 reference

Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism

21 January 2018

1 reference

Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.

21 January 2018

1 reference

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents

21 January 2018

1 reference

TNF-blocking agents and tuberculosis: new drugs illuminate an old topic

21 January 2018

1 reference

Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor

21 January 2018

1 reference

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

21 January 2018

1 reference

Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity.

21 January 2018

1 reference

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

21 January 2018

1 reference

Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages

21 January 2018

1 reference

Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47

21 January 2018

1 reference

Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/593174

1 reference

4 February 2018

PubMed ID

18954258

1 reference

4 February 2018